T. Várvölgyi

Increasing melanoma incidence in the elderly in North-East Hungary: is this a more serious problem than we thought?

G. Emri, É. Remenyik, B. Kiss, 2019, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Regional variability of melanoma incidence and prevalence in Hungary. Epidemiological impact of ambient UV radiation and socioeconomic factors.

G. Emri, A. Szegedi, E. Janka, 2021, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis

P. Hegyi, G. Emri, A. Soós, 2021, Frontiers in Oncology.

Cutaneous metastases at the sites of pembrolizumab-induced bullous pemphigoid lesions in a patient with melanoma

G. Emri, G. Méhes, L. Beke, 2022, Immunotherapy.

Cell therapy for burns – Our experiences in Debrecen

I. Juhász, G. Király, E. Nagy, 2017 .

Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1

G. Emri, A. Szegedi, A. Kapitány, 2023, Frontiers in oncology.

Combining Biomarkers for the Diagnosis of Metastatic Melanoma

E. Janka, B. Ványai, T. Várvölgyi, 2023, Journal of clinical medicine.

Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors

A. Kapitány, E. Janka, B. Ványai, 2024, Cancers.